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1. Introduction 
Intraperitoneal injections of carbobenzoxy (CBZ)- 
phenylacetyl and phenylpropionyl derivatives of 
ammo acids, especially derivatives with more than 
one aromatic group, were found to markedly inhibit 
the growth of Ehrlich ascites tumor in mice [l-3] .I 
Such derivatives also strongly inhibit a number of 
isolated enzyme systems (rat liver asparaginase and 
glutaminase [4,5] , rat liver and ovine brain gluta- 
mine synthetase [6,7] , rat liver NAD-synthetase [8] 
and the purine synthesizing system of pigeon and 
chicken liver [9]. Preliminary experiments with sus- 
pensions of Ehrlich ascites cells carried out in this 
department by G. Mor also revealed that ol,e-di-CBZ- 
L-lysine and N-CBZ-S-benzyl-L-cysteine markedly 
inhibit the incorporation of L-leucine and L-phenyl- 
alanine into ascites protein. The latter finding, how- 
ever, does not necessarily indicate that these com- 
pounds inhibit the protein synthesis as such (e.g., 
they might affect some ATP generating enzyme sys- 
tems). We decided therefore to investigate the effect 
of the above amino acid derivatives on cell-free pro- 
tein synthesizing systems prepared from Ehrlich 
ascites cells and from rat and mouse liver. The present 
paper deals with this subject. 
2. Materials and methods 
CBZ-L-phenylalanine,N-CBZ-S-benzyl-L-cysteine 
and a,e-di-CBZ-L-lysine were from Fluka A.G., 
Bucks, Switzerland. .CBZ-L-glutamic acid y-benzyl 
North-Holland Publishing Company - Amsterdam 
ester was prepared according to Hanby et al. [IO] . 
The preparation of N-phenylacetyl and N-phenylpro- 
pionyls-benzyl-L-cysteine will be described else- 
where [7]. All derivatives were used in the form of 
their alkali salts. These were prepared as described 
previously [l] for the preparation of the sodium salt 
of CBZ-L-phenylalanine. 
Free ribosomes from rat and mouse liver were 
prepared according to Bloemendal, Bont and Bene- 
detti [ 111. Free ribosomes from ascites cells were 
prepared as follows: Packed cells were washed and 
suspended in TKM buffer (Tris-HCl, 50 mM, pH 7.4; 
KCl, 25 mM and MgCls , 10 mM) containing 0.25 M 
sucrose, the suspension was passed through a French 
press (at a pressure of 8000 psi). The lysate was cen- 
trifuged at 17 000 g for 15 min, and from the super- 
natant free ribosomes were prepared according to 
Bloemendal et al. [ II] . For incorporation experi- 
ments, crude enzyme preparations were prepared 
according to Bloemendal et al. [ 1 l] . For the prepara- 
tion of fractions containing aminoacyl-tRNA synthe- 
tases the method of Geels et al. [ 121 was used. tRNA 
from the various sources was isolated essentially ac- 
cording to Bauer et al. [ 131. In all cases the enzymes, 
tRNA and ribosomes used in one experiment were 
from one and the same source. 
3. Results 
As can be seen from table 1, the amino acid deriva- 
tives tested strongly inhibited the poly U directed 
incorporation of phenylalanine into polypeptide by a 
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Table 1 
The effect of some amino acid derivatives on the poly U pro- 
moted incorporation of phenylalanine by incorporation sys- 
tems frome Ehrlich ascites, mouse and rat liver cells 
Inhibitor Final 
(mM) 
Ehrlich Mouse Rat 
ascites liver liver 
(7~ Inhibition) 
N-CBZ-S-benzyl- 
L-cysteine 1 .o 36 8 0 
2.5 87 49 16 
(Y,E- di-CBZ-L-lysine 0.25 68 10 0 
2.5 100 80 50 
CBZ-L-glutamic 
acid y-benzyl 
ester 2.5 71 44 13 
N-phenylacetyl-S- 
benzyl-L-cysteine 2.5 41 
5.0 67 
N-phenylpropionyl- 
0 0 
35 10 
S-benzyl-L- 
cysteine 5.0 
CBZ-L-phenylalanine 5 .O 
95 33 36 
82 _ 22 
The reaction mixtures contained in a final volume of 
0.22 ml: Tris-HCl, pH 7.2,0.06 M; KCl, 0.05 M; MgCla, 
0.01 M; DTT, 0.001 M; GTP, 0.0005 M; ATP, 0.0005 M; 
amino acid mixture, 5 X 10e5 M (each amino acid); 
[ 1 4C] phenylalanine, 0.2 PCi (sp.act. 5 13 &i/umole; PEP, 5 
X 10m3 M; PEP kinase (Boehringer) 2 bug protein; poly U, 40 
pg; tRNA, 20 fig; ribosomes 0.8-1.0 Az60nm units and 
aliquots of the corresponding enzyme fractions (necessary for 
optimal incorporation). The phenylalanine incorporation 
withoutgoly U was negligible in the ascites system and was 
approximately 20% of the total incorporation in the presence 
of poly U in the systems derived from mouse and rat liver. 
0.05 ml samples were counted for 5% hot TCA insoluble 
material. 
ribosomal incorporation system derived from Ehrlich 
ascites cells. The inhibition caused by these com- 
pounds in similar incorporation systems derived from 
mouse or rat liver was much less pronounced. The 
most active inhibitor of the compounds tested in all 
three incorporation systems was cu,e-di-CBZ-L-lysine. 
The extent of inhibition was calculated from results 
obtained after 15 min of incubation. The rates of 
phenylalanine incorporation were linear during the 
first 15 min of incubation in all three ribosomal sys- 
tems. The first step in the pathway leading from free 
phenylalanine to peptide bound phenylalanine is the 
activation of phenylalanine by the phenylalanyl- 
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Table 2 
The effect of some amino acid derivatives on the phenyl- 
alanyl-tRNA synthetase of Ehrlich ascites, rat and mouse 
liver cells. 
Inhibitor Final Ehrlich Mouse Rat 
cont. ascites liver liver 
(mM) (70 Inhibition) 
N-CBZ-S-benzyl- 
L-cysteine 0.25 3 27 16 
2.5 71 85 69 
a,c-di-CBZ-L- 
lysine 0.25 48 60 40 
2.5 92 96 92 
CBZ-L-glutamic 
acid y-benzyl- 
ester 0.25 26 24 25 
2.5 82 73 65 
N-phenylpropionyl- 
S-benzyl-L- 
cysteine 2.5 57 72 59 
The reaction mixture (37°C) contained in a final volume of 
0.22 ml: Tris-HCl, pH 7.4, 0.1 M; MgCl2,0.01 M; 
ATP, 0.002 M; mercaptoethanol, 0.02 M; bovine serum al- 
bumin, 40 pg; [ 14C]Phe, 0.2 &i (sp. act. 513 tiCi/pmole; 
tRNA from the various sources, 80-150 pg and aliquots of 
corresponding synthetases which give a linear reaction rate 
during the fist 10 min of reaction. 0.1 ml samples were 
counted for 5% cold TCA insoluble material. 
tRNA synthetase. We investigated therefore the effect 
of some of the above amino acid derivatives on the 
activation of phenylalanine. The results are shown in 
table 2. 
As can be seen from table 2, the amino acid deriva- 
tives inhibit the phenylalanyl-tRNA synthetase from 
ascites cells and from mouse and rat liver to the same 
extent, contrary to their effect on the poly-phenylala- 
nine formation as given in table 1. However, the Phe- 
tRNA synthetase is not the only step in the incor- 
poration of phenylalanine into polypeptide inhibited 
by the amino acid derivatives. As shown in table 3, 
cqe-di-CBZ-L-lysine and N-CBZ-S-benzyl-L-cysteine 
inhibited the poly U directed incorporation of phe- 
nylalanine from Phe-tRNA into polypeptide in an 
incorporation system obtained from Ehrlich ascites 
cells. Table 3 also shows that the extent of inhibition 
of phenylalanine incorporation depends upon the 
substrate used. With Phe-tRNA as substrate the inhi- 
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Table 3 
The effect of N-CBZ-S-benzyl-L-cysteine and 
Q, c-di-CBZ-L-1ysin.e on the poly U dependent phenyl- 
alanine by an incorporation system from Ehrlich ascites cells 
Inhibitor 
N-CBZ-S- 
enzyl-L- 
cysteine 
Final cont. Substrate 
Phe-tRNA Phenylalanine 
(mM) (% Inhibition) 
2.5 54 71 
cu,e-di-CBZ- 
L-lysine 2.5 41 95 
For methods see legend to table 1. With [’ 4C] Phe-tRNA 
(18 000 cpm corresponding to 24 pmoles of Phe-tRNA), ATP, 
tRNA and free [’ 4C] phenylalanine were omitted. 
bition was smaller than in a parallel experiment with 
free phenylalanine. 
4. Discussion 
N-CBZ-S-benzyl-L-cysteine and cY,e-di-CBZ-L-ly- 
sine inhibit the incorporation of leucine and phenyl- 
alanine into cellular protein of Ehrlich ascites cell 
suspensions. This inhibition may be due to the effect 
of the inhibitors on one or more systems directly or 
indirectly involved in the incorporation of amino 
acids into protein, such as penetration of amino acids 
into the cell, depletion of ATP or a direct influence 
on one or more of the reactions leading from intercel- 
lular amino acids to protein. The results described 
here show that one or more of the enzyme reactions 
directly involved in the amino acid incorporation is 
affected. Of the compounds tested N-CBZ-S-benzyl- 
L-cysteine and cr,~-di-CBZ-L-lysine strongly inhibited 
the phenylalanine incorporation in a cell-free system 
from ascites cells and to a much lesser degree in cell- 
free systems from mouse and rat liver. These com- 
pounds also exerted the strongest inhibitory effect on 
the growth of Ehrlich ascites tumor in mice. It is of 
course impossible at this stage to draw any conclusion 
about the correlation (if any) of these two inhibitory 
effects. It has to be taken into account that the in 
vitro conditions of our experiments on amino acid 
incorporation are greatly different from the in vivo 
conditions, such as ionic environment, the relative 
activity of the different enzymes involved and the use 
of synthetic messenger RNA and not natural messen- 
ger RNA. Phenylalanyl-tRNA synthetase from Ehrlich 
ascites cells and from rat and mouse liver is 
strongly inhibited by the different derivates used. 
However, not all aminoacyl-tRNA synthetases behave 
in this way; thus we found that valyl-tRNA synthe- 
tase was not inhibited at all under similar conditions 
by the same derivatives. From the results presented in 
tables 2 and 3 one can conclude that at least two of 
the amino acid derivatives, (Y, e-di-CBZ-L-lysine and 
N-CBZ-S-benzyl-L-cysteine interfere with the phenyl- 
alanine incorporation at more than one step in a cell- 
free system from Ehrlich ascites cells. More detailed 
investigations on the effect of the above-mentioned 
and similar amino acid derivates on the various iso- 
lated enzyme systems involved in protein biosynthesis 
are being carried out at present in our laboratory. 
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